BioCardia to Participate in Cantor Fitzgerald’s Cell and Genetic Medicines Conference
08 sept. 2022 07h00 HE
|
BioCardia, Inc.
SUNNYVALE, Calif., Sept. 08, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], today announced it will participate on a panel as a presenting company at Cantor Fitzgerald’s Cell and Genetic...